Abstract

Serine proteinase inhibitors (serpins) are classically regulators of extracellular proteolysis, however, recent evidence suggests that some function intracellularly. Such "ovalbumin" serpins include the human proteinase inhibitors 6 (PI-6), 8 (PI-8), and 9 (PI-9), plasminogen activator inhibitor 2, and the monocyte/neutrophil elastase inhibitor. PI-9 is a potent granzyme B (graB) inhibitor that has an unusual P1 Glu and is present primarily in lymphocytes. In a search for the murine equivalent of PI-9 we screened cDNA libraries, and performed reverse transcriptase-polymerase chain reaction on RNA isolated from leukocyte cell lines and from lymph nodes and spleens of allo-immunized mice. We identified 10 new ovalbumin serpin sequences: two resemble PI-8, two resemble PI-9, and the remaining six have no obvious human counterparts. By RNA analysis only one of the two sequences resembling PI-9 (designated SPI6) is present in mouse lymphocytes while the other (a partial clone designated mBM2A) is predominantly in testis. SPI6 comprises a 1.8-kilobase cDNA encoding a 374-amino acid polypeptide that is 68% identical to PI-9. mBM2A is 65% identical to PI-9 and over 80% identical to SPI6. Although the reactive loops of SPI6 and mBM2A differ from PI-9, both contain a Glu in a region likely to contain the P1-P1' bond. SPI6 produced in vitro using a coupled transcription/translation system formed an SDS-stable complex with human graB and did not interact with trypsin, chymotrypsin, leukocyte elastase, pancreatic elastase, thrombin, or cathepsin G. Recombinant SPI6 produced in a yeast expression system was used to examine the interaction with human graB in more detail. The second-order rate constant for the interaction was estimated as 8 x 10(4) M-1 s-1, and inhibition depended on the Glu in the SPI6 reactive center. The SPI6 gene was mapped to the same region on mouse chromosome 13 as Spi3, which encodes the murine homolog of PI-6. We conclude that even though their reactive centers are not highly conserved, SPI6 is a functional homolog of PI-9, and that the regulation of graB in the mouse may involve a second serpin encoded by mBM2A. Our identification of multiple sequence homologs of PI-8 and PI-9, and six new ovalbumin serpins, is consonant with the idea that the larger set of granule and other proteinases known to exist in the mouse (compared with human) is balanced by a larger array of serpins.

Highlights

  • The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) U96700 – U96709

  • The PAI-2, SCCA-1, SCCA-2, and maspin genes are on human chromosome 18 [8], whereas the proteinase inhibitors 6 (PI-6), PI-9, and MNEI genes are on human chromosome 6 (16 –19)

  • We have recently demonstrated that PI-9 is a potent inhibitor of the cytotoxic lymphocyte granule serine proteinase, granzyme B, and have suggested that PI-9 is produced by cytotoxic lymphocytes and other immune cells to counter misdirected graB released during target cell destruction [14]

Read more

Summary

EXPERIMENTAL PROCEDURES

General Methods—General recombinant DNA methods were performed according to Ref. 24. cDNA probes were labeled with [␣-32P]dATP (DuPont NEN) using the random hexamer method (PrimeA-Gene System, Promega). The mutagenic primer 5Ј-GCCATCATAGCATTTTGCTGTGCC-3Ј substitutes 337Glu in the SPI6 sequence with Ala. Following verification by DNA sequencing, the mutated SPI6 cDNA was subcloned from pHILD2 to pSVTf for use in the coupled transcription/translation system. A partial SPI6 cDNA clone (nucleotides 798 –1819) generated by the Erase-a-Base system was used in Southern hybridizations to identify a PvuII polymorphism in genomic DNA between Mus musculus (C57BL/ B6JEi) and Mus spretus (SPRET/Ei). This was used to probe a membrane containing approximately 2 ␮g of PvuII-digested genomic DNA from each of the 94 animals in the BSS panel [21]. Rowe at the Jackson Laboratory using the Map Manager program [38]

RESULTS
Popliteal in vitro
DISCUSSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.